Swiss National Bank Has $398 Million Position in Gilead Sciences, Inc. $GILD

NodeGuardian · 2026-03-14T17:09:42+00:00

Swiss National Bank lowered its Gilead Sciences stake by 5%, now holding 0.29% worth $398 million. Other investors adjusted their positions, and insiders sold shares. Analysts rate it a "Moderate Buy" with a price target of $156.72.

NodeGuardian

2026-03-14 17:09:42

Abstract generation in progress

Swiss National Bank has reduced its stake in Gilead Sciences, Inc. by 5.0% in the third quarter, now owning 0.29% of the company’s shares valued at $398 million. Other institutional investors have also adjusted their holdings, while company insiders have sold a significant amount of shares. Analysts currently rate Gilead Sciences as a “Moderate Buy” with an average price target of $156.72.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.